{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T22:29:36Z","timestamp":1789684176182,"version":"4.0.1"},"reference-count":24,"publisher":"MDPI AG","issue":"17","license":[{"start":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T00:00:00Z","timestamp":1757289600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Department of Defense Breast Cancer Research Program","award":["BC150685"],"award-info":[{"award-number":["BC150685"]}]},{"name":"Gerald and Flora Jo Mansfield Piltz Endowed Professorship II in Cancer Research","award":["BC150685"],"award-info":[{"award-number":["BC150685"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Background\/Objectives: Advanced breast cancer patients may develop bone metastases, leading to severe pain, fractures, and mortality. Current treatments have limited efficacy, necessitating targeted therapy approaches. Bone metastatic breast cancer cells secrete PTHrP that promotes tumor growth and bone degradation. Previous PTH\/PTHrP antagonists failed clinically due to short half-life and insufficient bone targeting. The present study evaluated the following two novel bone-targeted PTH antagonists fused to a collagen-binding domain (CBD) for enhanced bone localization: PTH(7-33)-CBD and [W2]PTH(1-33)-CBD. Methods: Intra-tibial and intra-iliac breast tumor models in mice were used to evaluate drug efficacy in reducing tumor burden and bone destruction. Results: Bioluminescent imaging, X-ray, and micro-CT analysis revealed that both drugs significantly reduced tumor burden and osteolysis compared to control, with [W2]PTH(1-33)-CBD additionally improving trabecular bone structure. Drug efficacy was confirmed in both intra-tibial and intra-iliac breast tumor models. Conclusions: These findings identify CBD-fused PTH\/PTHrP antagonists as a promising therapeutic strategy for breast cancer bone metastases.<\/jats:p>","DOI":"10.3390\/cancers17172933","type":"journal-article","created":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T10:29:07Z","timestamp":1757327347000},"page":"2933","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Bone Targeted Parathyroid Hormone Antagonists for Prevention of Breast Cancer Bone Metastases"],"prefix":"10.3390","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5797-7558","authenticated-orcid":false,"given":"Muralidharan","family":"Anbalagan","sequence":"first","affiliation":[{"name":"Department of Structural and Cellular Biology, Tulane University School of Medicine, New Orleans, LA 70112, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tulasi","family":"Ponnapakkam","sequence":"additional","affiliation":[{"name":"Department of Structural and Cellular Biology, Tulane University School of Medicine, New Orleans, LA 70112, USA"},{"name":"Department of Chemistry, Xavier University of Louisiana, New Orleans, LA 70125, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Binghao","family":"Zou","sequence":"additional","affiliation":[{"name":"Department of Structural and Cellular Biology, Tulane University School of Medicine, New Orleans, LA 70112, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jarvis","family":"Williams","sequence":"additional","affiliation":[{"name":"Department of Structural and Cellular Biology, Tulane University School of Medicine, New Orleans, LA 70112, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fouad","family":"Saeg","sequence":"additional","affiliation":[{"name":"Department of Structural and Cellular Biology, Tulane University School of Medicine, New Orleans, LA 70112, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0642-6630","authenticated-orcid":false,"given":"Matthew E.","family":"Burow","sequence":"additional","affiliation":[{"name":"Section of Hematology & Medical Oncology, Department of Medicine, Tulane University School of Medicine, New Orleans, LA 70112, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert C.","family":"Gensure","sequence":"additional","affiliation":[{"name":"Dartmouth Health Children\u2019s, Geisel School of Medicine, Lebanon, NH 03756, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian G.","family":"Rowan","sequence":"additional","affiliation":[{"name":"Department of Structural and Cellular Biology, Tulane University School of Medicine, New Orleans, LA 70112, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,9,8]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s10549-011-1721-x","article-title":"Mortality following bone metastasis and skeletal-related events among women with breast cancer: A population-based analysis of U.S. Medicare beneficiaries, 1999\u20132006","volume":"131","author":"Sathiakumar","year":"2012","journal-title":"Breast Cancer Res. Treat."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/BF02032890","article-title":"The expression of parathyroid hormone-related protein in human breast cancer with skeletal metastases","volume":"24","author":"Kohno","year":"1994","journal-title":"Surg. Today"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"4655","DOI":"10.1172\/JCI46134","article-title":"PTHrP drives breast tumor initiation, progression, and metastasis in mice and is a potential therapy target","volume":"121","author":"Li","year":"2011","journal-title":"J. Clin. Investig."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"e157390","DOI":"10.1172\/jci.insight.157390","article-title":"Parathyroid hormone 1 receptor signaling mediates breast cancer metastasis to bone in mice","volume":"8","author":"Swami","year":"2023","journal-title":"JCI Insight"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1038\/sj.bjc.6600757","article-title":"The parathyroid hormone-related protein receptor is expressed in breast cancer bone metastases and promotes autocrine proliferation in breast carcinoma cells","volume":"88","author":"Hoey","year":"2003","journal-title":"Br. J. Cancer"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"S46","DOI":"10.3816\/CBC.2005.s.004","article-title":"Molecular mechanisms of breast cancer metastases to bone","volume":"5","author":"Guise","year":"2005","journal-title":"Clin. Breast Cancer"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Frieling, J.S., and Lynch, C.C. (2019). Proteolytic Regulation of Parathyroid Hormone-Related Protein: Functional Implications for Skeletal Malignancy. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20112814"},{"key":"ref_8","first-page":"Cd008455","article-title":"Interventions for treating bisphosphonate-related osteonecrosis of the jaw (BRONJ)","volume":"2","author":"Rollason","year":"2016","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1016\/j.joms.2014.04.031","article-title":"American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw\u20142014 update","volume":"72","author":"Ruggiero","year":"2014","journal-title":"J. Oral Maxillofac. Surg."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1038\/s41589-021-00929-w","article-title":"Precise druggability of the PTH type 1 receptor","volume":"18","author":"Sutkeviciute","year":"2022","journal-title":"Nat. Chem. Biol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.ando.2023.04.001","article-title":"New directions in the treatment of hypoparathyroidism","volume":"84","author":"Hamny","year":"2023","journal-title":"Ann. D\u2019endocrinologie"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1074\/jbc.M408270200","article-title":"Novel parathyroid hormone (PTH) antagonists that bind to the juxtamembrane portion of the PTH\/PTH-related protein receptor","volume":"280","author":"Shimizu","year":"2005","journal-title":"J. Biol. Chem."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1097\/CAD.0000000000001051","article-title":"Novel bone-targeted parathyroid hormone-related peptide antagonists inhibit breast cancer bone metastases","volume":"32","author":"Ponnapakkam","year":"2021","journal-title":"Anticancer Drugs"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S1535-6108(03)00132-6","article-title":"A multigenic program mediating breast cancer metastasis to bone","volume":"3","author":"Kang","year":"2003","journal-title":"Cancer Cell"},{"key":"ref_15","first-page":"e4260","article-title":"Models of bone metastasis","volume":"4","author":"Campbell","year":"2012","journal-title":"J. Vis. Exp."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ccell.2014.11.017","article-title":"The osteogenic niche promotes early-stage bone colonization of disseminated breast cancer cells","volume":"27","author":"Wang","year":"2015","journal-title":"Cancer Cell"},{"key":"ref_17","first-page":"53982","article-title":"Intra-iliac Artery Injection for Efficient and Selective Modeling of Microscopic Bone Metastasis","volume":"26","author":"Yu","year":"2016","journal-title":"J. Vis. Exp."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1158\/1541-7786.MCR-16-0297-T","article-title":"Dual Src Kinase\/Pretubulin Inhibitor KX-01, Sensitizes ERalpha-negative Breast Cancers to Tamoxifen through ERalpha Reexpression","volume":"15","author":"Anbalagan","year":"2017","journal-title":"Mol. Cancer Res."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"e10587","DOI":"10.1002\/jbm4.10587","article-title":"Parathyroid Hormone-Related Protein Inhibition Blocks Triple-Negative Breast Cancer Expansion in Bone Through Epithelial to Mesenchymal Transition Reversal","volume":"6","author":"Li","year":"2022","journal-title":"JBMR Plus"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"102085","DOI":"10.1016\/j.toxrep.2025.102085","article-title":"Acute toxicological evaluation of bone-targeted parathyroid hormone-related peptide (PTHrP) antagonist to inhibit breast cancer metastases to bone","volume":"15","author":"Ponnapakkam","year":"2025","journal-title":"Toxicol. Rep."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"e90874","DOI":"10.1172\/jci.insight.90874","article-title":"Prevention of breast cancer skeletal metastases with parathyroid hormone","volume":"2","author":"Swami","year":"2017","journal-title":"JCI Insight"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"7120979","DOI":"10.1155\/2018\/7120979","article-title":"PTH1R-CaSR Cross Talk: New Treatment Options for Breast Cancer Osteolytic Bone Metastases","volume":"2018","author":"Yang","year":"2018","journal-title":"Int. J. Endocrinol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1056\/NEJMoa1813904","article-title":"Alpelisib for PIK3CA-Mutated, Hormone Receptor-Positive Advanced Breast Cancer","volume":"380","author":"Ciruelos","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1056\/NEJMoa1607303","article-title":"Palbociclib and Letrozole in Advanced Breast Cancer","volume":"375","author":"Finn","year":"2016","journal-title":"N. Engl. J. Med."}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/17\/17\/2933\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:41:45Z","timestamp":1760035305000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/17\/17\/2933"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,8]]},"references-count":24,"journal-issue":{"issue":"17","published-online":{"date-parts":[[2025,9]]}},"alternative-id":["cancers17172933"],"URL":"https:\/\/doi.org\/10.3390\/cancers17172933","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,8]]}}}